North Carolina Novo Nordisk’s GLP-1 Pill Makes Key Progress Oct 21, 2025 Novo Nordisk's pill, oral semaglutide, has scored approval for slashing cardiovascular risks, further confirming its health benefits beyond diabetes treatment.
Health & Wellness Cyberattack Disrupts UnitedHealth’s Change Healthcare for 4th Day Feb 24, 2024 TL/DR - UnitedHealth Group, the largest health-care company in the U.S., disclosed that a "suspected…